We know many of the proteins that drive illnesses like cancer, but most are considered “undruggable” by experts. However, small molecules have evolved in several other species to target these proteins. Now, we have a way to find them and develop them into medicines.
We are sequencing thousands of microbial genomes to build a diverse database.
Our proprietary algorithm searches genomes for small molecule inhibitors of selected target proteins.
Our unique synthetic biology platform enables us to produce new molecules.
Our team of leading scientists are developing these potent molecules into medicines.